Latest news with #KWR
Time of India
8 hours ago
- Entertainment
- Time of India
BTS's Suga donates 5 BILLION to hospital supporting children with Autism; sets new record for largest donation by K-Pop idol
BTS member Suga has made history with a record-breaking donation to Severance Hospital in Seoul, funding the establishment of the Min Yoongi Treatment Centre, dedicated to supporting children with autism spectrum disorder (ASD). According to reports on koreaboo, Suga shelled out KWR 5 billion (approximately USD 3.64 million), marking the largest single contribution ever made by a K-pop idol to a medical institution. The donation will help the new facility offer a range of tailored treatments, including speech, psychological, and behavioural therapy. It will also serve as a research hub, aiming to promote the social independence of individuals with ASD. The project is a collaboration between Suga and Professor Cheon Geun Ah from the hospital's Pediatric Psychiatry Department, with whom he has been working since November 2024. In a heartfelt statement reported by koreaboo, Suga shared his motivation behind the donation, 'During the past seven months of preparing this program and volunteering with Professor Cheon, I genuinely felt that music can be a valuable method for expressing one's feelings and communicating with the world. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Memperdagangkan CFD Emas dengan salah satu spread terendah? IC Markets Undo Being part of the treatment process for children with autism spectrum disorder has been a big blessing and source of happiness for me. I will continue to support efforts that will help more children integrate into society.' MIND Program: Music at the Heart of Therapy At the core of the new centre will be the MIND Program which is short for Music, Interaction, Network, and Diversity, which Suga helped co-develop. This innovative therapy model uses music to enhance communication, emotional expression, and social interaction in children with ASD. Participants will engage in singing, instrument-playing, and music-based writing exercises to build confidence and interpersonal skills while celebrating their individuality. Suga has been hands-on in the development of the program. Between March and June this year, he volunteered his weekends to work directly with children, even teaching them how to play instruments. The sessions, he said, revealed how powerfully music can unlock emotional and social growth. The treatment centre is scheduled for completion in September 2025, and will significantly expand the hospital's existing pediatric mental health services.
Yahoo
15-06-2025
- Business
- Yahoo
Jefferies Turns Bullish on Quaker Chemical, Sees Upside Potential
Quaker Chemical Corporation (NYSE:KWR) is one of the 8 cheap beginner stocks to buy right now. On June 9, Quaker Chemical Corporation (NYSE:KWR) was upgraded from Hold to Buy by Jefferies analysts. In keeping with its optimistic assessment of the company's performance, the firm also increased its price target from $115 to $146. Despite challenges in the end markets, Jefferies analysts emphasized Quaker Chemical's strong margins and return on capital employed (ROCE), which are still higher than 2019 levels. Over the course of four years, they observed a notable decline in the company's EV/EBITDA, which has caused share prices to drop to levels comparable to those at which earnings per share were less than $5. According to the analysts, Quaker Chemical Corporation (NYSE:KWR) is a "good quality-at-a-reasonable-price candidate," with a free cash flow yield of 7%. By highlighting the company's competitive edge and cyclical leverage, they predict that earnings will likely grow in 2026. Jefferies also believes that Quaker Chemical's shares may rerate relative to its peers, which may mean that the stock could reach $245 in 2027. In the best-case scenario, analysts predict that KWR could triple by 2030. Quaker Chemical Corporation (NYSE:KWR) is a global provider of industrial products for heavy manufacturing sectors. The company offers a wide range of products, with a focus on rolling lubricants, hydraulic fluids, forming and forging fluids, corrosion inhibitors, and metal removal fluids. While we acknowledge the potential of KWR as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. Read More: and Disclosure: None. Sign in to access your portfolio
Yahoo
15-06-2025
- Business
- Yahoo
Jefferies Turns Bullish on Quaker Chemical, Sees Upside Potential
Quaker Chemical Corporation (NYSE:KWR) is one of the 8 cheap beginner stocks to buy right now. On June 9, Quaker Chemical Corporation (NYSE:KWR) was upgraded from Hold to Buy by Jefferies analysts. In keeping with its optimistic assessment of the company's performance, the firm also increased its price target from $115 to $146. Despite challenges in the end markets, Jefferies analysts emphasized Quaker Chemical's strong margins and return on capital employed (ROCE), which are still higher than 2019 levels. Over the course of four years, they observed a notable decline in the company's EV/EBITDA, which has caused share prices to drop to levels comparable to those at which earnings per share were less than $5. According to the analysts, Quaker Chemical Corporation (NYSE:KWR) is a "good quality-at-a-reasonable-price candidate," with a free cash flow yield of 7%. By highlighting the company's competitive edge and cyclical leverage, they predict that earnings will likely grow in 2026. Jefferies also believes that Quaker Chemical's shares may rerate relative to its peers, which may mean that the stock could reach $245 in 2027. In the best-case scenario, analysts predict that KWR could triple by 2030. Quaker Chemical Corporation (NYSE:KWR) is a global provider of industrial products for heavy manufacturing sectors. The company offers a wide range of products, with a focus on rolling lubricants, hydraulic fluids, forming and forging fluids, corrosion inhibitors, and metal removal fluids. While we acknowledge the potential of KWR as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. Read More: and Disclosure: None. Sign in to access your portfolio
Yahoo
14-03-2025
- Business
- Yahoo
Is There Now An Opportunity In Quaker Chemical Corporation (NYSE:KWR)?
Quaker Chemical Corporation (NYSE:KWR), is not the largest company out there, but it saw significant share price movement during recent months on the NYSE, rising to highs of US$158 and falling to the lows of US$125. Some share price movements can give investors a better opportunity to enter into the stock, and potentially buy at a lower price. A question to answer is whether Quaker Chemical's current trading price of US$130 reflective of the actual value of the mid-cap? Or is it currently undervalued, providing us with the opportunity to buy? Let's take a look at Quaker Chemical's outlook and value based on the most recent financial data to see if there are any catalysts for a price change. See our latest analysis for Quaker Chemical Good news, investors! Quaker Chemical is still a bargain right now. Our valuation model shows that the intrinsic value for the stock is $212.95, but it is currently trading at US$130 on the share market, meaning that there is still an opportunity to buy now. What's more interesting is that, Quaker Chemical's share price is quite volatile, which gives us more chances to buy since the share price could sink lower (or rise higher) in the future. This is based on its high beta, which is a good indicator for how much the stock moves relative to the rest of the market. Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Buying a great company with a robust outlook at a cheap price is always a good investment, so let's also take a look at the company's future expectations. Quaker Chemical's earnings over the next few years are expected to increase by 38%, indicating a highly optimistic future ahead. This should lead to more robust cash flows, feeding into a higher share value. Are you a shareholder? Since KWR is currently undervalued, it may be a great time to accumulate more of your holdings in the stock. With a positive outlook on the horizon, it seems like this growth has not yet been fully factored into the share price. However, there are also other factors such as financial health to consider, which could explain the current undervaluation. Are you a potential investor? If you've been keeping an eye on KWR for a while, now might be the time to make a leap. Its prosperous future outlook isn't fully reflected in the current share price yet, which means it's not too late to buy KWR. But before you make any investment decisions, consider other factors such as the track record of its management team, in order to make a well-informed buy. Since timing is quite important when it comes to individual stock picking, it's worth taking a look at what those latest analysts forecasts are. At Simply Wall St, we have the analysts estimates which you can view by clicking here. If you are no longer interested in Quaker Chemical, you can use our free platform to see our list of over 50 other stocks with a high growth potential. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
